Main navigation
You are here
- Home
- Investors
- Presentations & webcasts
1999 Presentations
24 February 2000
6 December 1999
26 July 1999
Fourth quarter and full year results 1999
Slide presentation - (PDF 462 kb)
6 December 1999
R&D day
CNS - Ron Polinsky - (PDF 303 kb)
Cardiovascular - Hamish Cameron - (PDF 672 kb)
Discovery - Jan M Lundberg - (PDF 618 kb)
Gastrointestinal - Martin Nicklasson - (PDF 328 kb)
Infection - Aileen Allsop - (PDF 135 kb)
Oncology - Brent Vose - (PDF 613 kb)
Pain - Carl-Johan Dalsgaard - (PDF 313 kb)
Respiratory - Colin Reddrop - (PDF 613 kb)
Strategy - Claes Wilhelmsson - (PDF 502 kb)
Conclusion - Tom McKillop - (PDF 132 kb)
26 July 1999
Second quarter and half year results 1999
Not signed in
Page tools
Share price
- London
-
26.95 GBP - New York
-
44.82 USD - Stockholm
-
310.10 SEK
At 21-Nov-2009 10:43 GMT
Detailed share priceStock symbol - AZN
On LSE, NYSE and OMX
Introduction to AstraZeneca
Our responsibility
We continue to communicate openly on a range of issues, including:
